Here’s Why La Jolla Pharmaceuticals Company Is Soaring
What happened. After announcing that its phase 3 ATHOS-3 study would be published in a prestigious medical journal, clinical-stage biotech La Jolla Pharmaceutical (NASDAQ:LJPC) saw its shares jump by 24% as of 4 p.m. EDT on Thursday.
La Jolla Pharmaceutical Company (LJPC) And Its Technical Chart Is Now Center StageNY Stock News
Somewhat Favorable News Coverage Very Likely to Affect La Jolla Pharmaceutical Company (LJPC) Stock PriceThe Cerbat Gem
La Jolla Pharmaceutical Company (LJPC) Moves Higher on Volume Spike for May 18Equities.com
all 41 news articles >>
Source: pharmaceutical – Google News
Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd